These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3022429)

  • 1. Chronic lead exposure alters dopaminergic mechanisms in rat pituitary.
    Lucchi L; Govoni S; Memo M; Missale C; Spano PF; Trabucchi M
    Toxicol Lett; 1986 Sep; 32(3):255-60. PubMed ID: 3022429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
    Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
    Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation.
    Quik M; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):141-5. PubMed ID: 212684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging process affects a single class of dopamine receptors.
    Memo M; Lucchi L; Spano PF; Trabucchi M
    Brain Res; 1980 Dec; 202(2):488-92. PubMed ID: 7437912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.
    Valerio A; Alberici A; Tinti C; Spano P; Memo M
    J Neurochem; 1994 Apr; 62(4):1260-6. PubMed ID: 8133260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
    Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
    Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine receptors mediating the stimulation and the inhibition of adenylate cyclase in rat prostate gland.
    Amenta D; Cavallotti C; Amenta F
    Neurosci Lett; 1987 Jun; 77(1):66-70. PubMed ID: 3037450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-2 dopamine receptor-mediated inhibition of pro-opiomelanocortin synthesis in rat intermediate lobe. Abolition by pertussis toxin or activators of adenylate cyclase.
    Cote TE; Felder R; Kebabian JW; Sekura RD; Reisine T; Affolter HU
    J Biol Chem; 1986 Apr; 261(10):4555-61. PubMed ID: 3957908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells.
    Memo M; Carboni E; Trabucchi M; Carruba MO; Spano PF
    Brain Res; 1985 Nov; 347(2):253-7. PubMed ID: 2415214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
    Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
    Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal adenylate cyclase-inhibiting dopamine D2 receptors are not affected by the aging process.
    Missale C; Castelletti L; Pizzi M; Memo M; Carruba MO; Spano PF
    Neurosci Lett; 1987 Mar; 75(1):38-42. PubMed ID: 3033556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
    Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lead treatment induces in rat a specific and differential effect on dopamine receptors in different brain areas.
    Lucchi L; Memo M; Airaghi ML; Spano PF; Trabucchi M
    Brain Res; 1981 Jun; 213(2):397-404. PubMed ID: 7248763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
    Lucchi L; Moresco RM; Govoni S; Trabucchi M
    Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic ethanol treatment on adenylate cyclase activity in rat striatum.
    Lucchi L; Covelli V; Anthopoulou H; Spano PF; Trabucchi M
    Neurosci Lett; 1983 Sep; 40(2):187-92. PubMed ID: 6314211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age related differences in dopamine-stimulated adenylate cyclase sensitivity to "in vivo" chronic ethanol treatment.
    Lucchi L; Govoni S; Trabucchi M
    Alcohol; 1984; 1(4):263-7. PubMed ID: 6100231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of intermediate pituitary corticotropin-releasing hormone receptors by dopamine.
    Shiver T; Familari M; Aguilera G
    Endocrinology; 1992 Apr; 130(4):2299-304. PubMed ID: 1347742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.